WPRIM Management System> DCMS> Journal of International Oncology> 2017> 44> 1

Volume: 44 Issue: 1

1. MicroRNAs in exsomes-the new-type of regulatory molecules in the tumor progression Page:24—26
2. Association between EGFR mutation status and efficacy of first-line EGFR-TKI in patients with ;advanced non-small cell lung cancer Page:19—23
3. Randomized controlled clinical trial of nedaplatin combined with gemcitabine and cisplatin combined ;with gemcitabine in the treatment of advanced lung squamous cell carcinoma Page:15—18
4. Targeting Pyk2 gene on the proliferation,invasion and migration induction of hepatocelluar cancer ;Hep3B cells Page:1—5
5. The role of microRNA-32 in hepatocarcinoma Page:75—77
6. Targeted therapies for gastrointestinal cancer Page:71—74
7. The clinical pathological indicators related with prognosis of esophageal squamous cell carcinoma Page:67—70
8. Advances of immune checkpoint blockades in the treatment of digestive cancers Page:63—66
9. Therapy for non-small cell lung cancer patients with solitary bone metastases Page:60—62
10. Appliation of the combination of antiangiogenic agents and EGFR-TKIs in advanced NSCLC treatment Page:57—59
11. Driver genes and targeted drugs in lung cancer Page:53—56
12. Safety of the nipple-sparing mastectomy in treating breast cancer Page:49—52
13. The application of circulating tumor cells in the diagnosis and treatment of breast cancer Page:45—48
14. Application of bevacizumab for malignant brain edema Page:41—44
15. Nucleic acid aptamer and its research progress in glioma Page:38—40
16. Research of microbiota and tumor immunomodulatory Page:34—37
17. Hypoxic tumor microenvironment and immune response Page:31—33
18. Expression and role of Golgi phosphoprotein 3 in cancer Page:27—30
19. Expressions and clinical significance of AEG-1 and BECN-1 in papillary thyroid carcinoma Page:11—14
20. Diagnostic value of combined detection of serum DKK1 and EB virus VCA-IgA for nasopharyngeal car-cinoma Page:6—10